Explore Now
NEW DELHI: At least 10 smallcap and midcap companies have seen expansion in profit margins for four straight quarters now. For some of them, the margin expansion came despite a rise in raw material cost. The managements of these companies are sounding confident of sustaining the trend.
MindTree said its PAT margin improved to 16.13 per cent in December quarter from 13.17 per cent in September quarter, 11.15 per cent in June quarter and 10.05 per cent in March quarter. Over the last four quarters, PAT margin for this IT firm has risen 610 basis points over December 2020 s 10.02 per cent.
Analysts said IT company s margins are industry-leading in the midcap space, led by revenue growth, all-time high utilisation and sustained high offshoring. The company management is confident of sustaining Ebitda margins at nearly 20 per cent. Prabhudas Lilladher is expecting the company to clock Ebitda margins of 19.6 per cent in FY22 and 19.5 in FY23.
India Household Insecticide Market | Cockroach, Rat & Other Repellent Market Segment Is Expected To Grow At Above 8% CAGR In The Coming Years: Bonafide Research sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Search jobs 28-Jan-2021 Future Market Insights Analyzes Impact of COVID-19 on Pharma-grade Synthetic Camphor Market; Stakeholders to Focus on Long-term Dimensions
Report tracks some of the key companies operating in the
global pharma-grade synthetic camphor market. Representative players
included in the global pharma-grade synthetic camphor market report are
Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited,
Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem
International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation,
Prinova Group LLC. and Fengchen Group Co., Ltd. Manufactures are
focusing on improvement of the supply chain which expected to provide
huge opportunities to them over the forecast period.
Mangalam Organics Ltd Q3FY21 PAT surges to Rs. 29.78 crore
Posted On:
Mangalam Organics Limited has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.107.77 crores during the period ended December 31, 2020 as compared to Rs.86.37 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.29.78 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.14.32 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.34.78 for the period ended December 31, 2020 as compared to Rs.16.73 for the period ended September 30, 2020.